2004
DOI: 10.1111/j.1365-2133.2004.06040.x
|View full text |Cite
|
Sign up to set email alerts
|

Overview of studies of treatments for hand eczema-the EDEN hand eczema survey

Abstract: Most 'trials' in hand eczema are not RCTs. Internally controlled (left/right) studies were common. Based on the poor overall quality of reporting, most RCTs of hand eczema trials are not adequate to guide clinical practice. Future trials of hand eczema should be randomized, using a parallel group or self-controlled design. Research is needed to develop validated and clinically relevant outcome measures. Most of the remaining issues relating to poor quality of existing evidence can be relatively easily dealt wi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
50
0
5

Year Published

2007
2007
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 82 publications
(55 citation statements)
references
References 13 publications
0
50
0
5
Order By: Relevance
“…19 Current treatment strategies are largely based on clinical experience and may differ from country to country. 7,8,20 Few therapies have been evaluated in randomized, controlled trials, 21 and the trials that have been conducted typically have not distinguished types of eczema. Figure 3 shows an algorithm for the management of hand eczema.…”
Section: Hand Eczemamentioning
confidence: 99%
“…19 Current treatment strategies are largely based on clinical experience and may differ from country to country. 7,8,20 Few therapies have been evaluated in randomized, controlled trials, 21 and the trials that have been conducted typically have not distinguished types of eczema. Figure 3 shows an algorithm for the management of hand eczema.…”
Section: Hand Eczemamentioning
confidence: 99%
“…sults of randomized trials, all of them were performed in the eighties (Table 1). According to current standards they hardly fulfill criteria for evidence-based medicine [3,20,30]. They included low numbers of patients and follow-up was only 5 weeks to 6 months (median 4 months).…”
Section: Discussionmentioning
confidence: 99%
“…Severity-scores for symptoms were different and simplified encompassing several symptoms. Due to the absence of accepted severity-scores in both eczema and psoriasis [5,20,30,31] a comparison of trials is difficult. Regarding RT single doses of 0.9 Gy -4 Gy and total doses of 2.7 Gy -24 Gy were used in these trials.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Gdy terapia miejscowa wydaje się niewystarczająca, kolejną opcją leczniczą jest włączenie systemowych preparatów glikokortykosteroidowych. W piśmiennictwie relacjonowane są także próby leczenia azatiopryną, cyklosporyną, mykofenolanem mofetylu czy acytretyną [13][14][15][16]. W każdym przypadku warto jednak indywidualnie rozważyć rachunek zysków i strat wynikających ze skutków ubocznych danej terapii ogólnej.…”
Section: Introductionunclassified